✦ LIBER ✦

A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias

✍ Scribed by Maria Goldaniga; Andrea Ferrario; Sergio Cortelazzo; Andrea Guffanti; Enzo Pavone; Achille Ambrosetti; Luigi Marcheselli; Francesca Rossi; Stefano Luminari; Andrea Rossi; Lilla Cro; Massimo Federico; Giorgio Lambertenghi Deliliers; Luca Baldini

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 102 KB
Volume: 83
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical and laboratory approach to

The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias

✍ Curtis A. Hanson; William G. Morice 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Evolving clinical landscape of chronic h

Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

✍ Tommaso Stroffolini; Piero L. Almasio; Evangelista Sagnelli; Alfonso Mele; Giova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the prevalence of HBeAg and viral and non‐viral co‐factors of liver disease. A cross‐sectional multicenter survey was undertaken, whic

Routine clinical use of alemtuzumab in p

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria

✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono

Co-expression of Mac-1 and p150,95 on CD

Co-expression of Mac-1 and p150,95 on CD5+ B cells. Structural and functional characterization in a human chronic lymphocytic leukemia

✍ Antonio De La Hera; Melchor Alvarez-Mon; Francisco Sanchez-Madrid; Carlos Martin 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Major histocompatibility complex control

Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease

✍ Takashi Okada; Fumiaki Takiura; Katsutoshi Tokushige; Shingo Nozawa; Tomoharu Ki 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 751 KB

Diagnosis and clinical impact of occult

Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: A multicenter study

✍ Sagnelli Evangelista; Imparato Michele; Coppola Nicola; Pisapia Raffaella; Sagne 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract Occult hepatitis B virus (HBV) infection in patients with chronic hepatitis C has been found associated with severe liver damage, low response to interferon treatment and increased risk of developing HCC. However, doubts remain on its clinical impact and the sensitivity and specificity